Delivery Order SPE2DX22D0059-SPE2D825F0JWP

This delivery order, awarded September 1, 2025, represents a child contract under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The specific delivery order carries a ceiling value of $6,139.94 with firm fixed pricing and an ultimate completion date of September 2, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was competitively awarded this non-set-aside contract to supply pharmaceutical products and medical supplies to support federal medical procurement needs, particularly for military and veteran healthcare systems. The award is funded through the Defense Logistics Agency's Medical Supply Chain division.

As a child order under the DLA's comprehensive pharmaceutical support vehicle, this delivery fulfills part of AmerisourceBergen Drug Corp's role as a critical vendor supplying a broad spectrum of pharmaceutical products including brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities. The company's extensive federal contract portfolio demonstrates its capability to meet competitive procurement requirements across multiple therapeutic domains and customer bases, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA Troop Support Medical's strategic approach to pharmaceutical procurement through prime vendor contracts enables flexible and comprehensive medical supply support globally.